• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期再灌注期间,不依赖一氧化氮的可溶性鸟苷酸环化酶刺激或激活可限制梗死面积。

NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.

作者信息

Bice Justin S, Keim Yvonne, Stasch Johannes-Peter, Baxter Gary F

机构信息

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK.

出版信息

Cardiovasc Res. 2014 Feb 1;101(2):220-8. doi: 10.1093/cvr/cvt257. Epub 2013 Nov 20.

DOI:10.1093/cvr/cvt257
PMID:24259501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3896250/
Abstract

AIMS

Guanylyl cyclase-cyclic guanosine monophosphate signalling plays an important role in endogenous cardioprotective signalling. The aim was to assess the potential of direct pharmacological activation and stimulation of soluble guanylyl cyclase, targeting different redox states of the enzyme, to limit myocardial necrosis during early reperfusion.

METHODS AND RESULTS

Rat isolated hearts were subjected to reversible left coronary artery occlusion (ischaemia-reperfusion) and infarct size was assessed by the tetrazolium staining technique. Administration during early reperfusion of BAY 41-2272, an NO-independent, haem-dependent stimulator of soluble guanylyl cyclase targeting the reduced state, or BAY 60-2770, an NO-independent, haem-independent activator targeting the oxidized state, significantly limited infarct size. Inhibition of NO synthesis did not abrogate this protection, but exogenous perfusion of NO with BAY 41-2272 produced a synergistic effect. The haem site oxidiser, ODQ abrogated the protection afforded by BAY 41-2272 but potentiated the protection afforded by BAY 60-2770. Targeting both the reduced and oxidized forms of sGC together did not afford additive protection.

CONCLUSIONS

Targeting either reduced or oxidized forms of sGC during early reperfusion affords cardioprotection, providing support for the concept that direct sGC manipulation at reperfusion has therapeutic potential for the management of acute myocardial infarction.

摘要

目的

鸟苷酸环化酶 - 环磷酸鸟苷信号传导在内源性心脏保护信号传导中起重要作用。本研究旨在评估直接药理激活和刺激可溶性鸟苷酸环化酶(针对该酶的不同氧化还原状态)在早期再灌注期间限制心肌坏死的潜力。

方法与结果

对大鼠离体心脏进行可逆性左冠状动脉闭塞(缺血 - 再灌注),并通过四氮唑染色技术评估梗死面积。在早期再灌注期间给予BAY 41 - 2272(一种不依赖一氧化氮、依赖血红素的可溶性鸟苷酸环化酶刺激剂,作用于还原态)或BAY 60 - 2770(一种不依赖一氧化氮、不依赖血红素的激活剂,作用于氧化态),可显著限制梗死面积。抑制一氧化氮合成并未消除这种保护作用,但外源性灌注一氧化氮与BAY 41 - 2272产生协同效应。血红素位点氧化剂ODQ消除了BAY 41 - 2272提供的保护作用,但增强了BAY 60 - 2770提供的保护作用。同时靶向可溶性鸟苷酸环化酶的还原态和氧化态并未提供额外的保护作用。

结论

在早期再灌注期间靶向可溶性鸟苷酸环化酶的还原态或氧化态均可提供心脏保护,这为再灌注时直接操纵可溶性鸟苷酸环化酶对急性心肌梗死的治疗具有潜在价值这一概念提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/31e231d4c036/cvt25705.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/7b3e54cb58f5/cvt25701.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/768f43e6343e/cvt25702.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/905955843451/cvt25703.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/fa5ab3db686c/cvt25704.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/31e231d4c036/cvt25705.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/7b3e54cb58f5/cvt25701.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/768f43e6343e/cvt25702.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/905955843451/cvt25703.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/fa5ab3db686c/cvt25704.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fc1/3896250/31e231d4c036/cvt25705.jpg

相似文献

1
NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.早期再灌注期间,不依赖一氧化氮的可溶性鸟苷酸环化酶刺激或激活可限制梗死面积。
Cardiovasc Res. 2014 Feb 1;101(2):220-8. doi: 10.1093/cvr/cvt257. Epub 2013 Nov 20.
2
Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.血红素氧化可溶性鸟苷酸环化酶与 BAY 60-2770 在人血小板中的激活导致环鸟苷酸信号通路的过度刺激。
PLoS One. 2012;7(11):e47223. doi: 10.1371/journal.pone.0047223. Epub 2012 Nov 8.
3
Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.可溶性鸟苷酸环化酶激活预处理可预防缺血后炎症反应,并减少血红素加氧酶-1 敲除小鼠的硝酸盐耐受。
Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H521-32. doi: 10.1152/ajpheart.00810.2012. Epub 2013 Jun 14.
4
Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.西那卡塞,一种新型可溶性鸟苷酸环化酶激活剂,可预防缺血/再灌注损伤:硫化氢的作用。
Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1347-54. doi: 10.1152/ajpheart.00544.2011. Epub 2012 Jan 20.
5
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.血红素氧化诱导降解后可溶性鸟苷酸环化酶激活或稳定的不同分子需求。
Br J Pharmacol. 2009 Jul;157(5):781-95. doi: 10.1111/j.1476-5381.2009.00263.x. Epub 2009 May 18.
6
Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.过氧化氢对离体大鼠髂动脉通过一氧化氮/可溶性鸟苷酸环化酶/环磷酸鸟苷途径舒张的影响。
Free Radic Res. 2015;49(12):1479-87. doi: 10.3109/10715762.2015.1089987.
7
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.在心血管疾病中使用BAY 41-2272对可溶性鸟苷酸环化酶进行不依赖一氧化氮的刺激。
Cardiovasc Drug Rev. 2007 Spring;25(1):30-45. doi: 10.1111/j.1527-3466.2007.00003.x.
8
Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.缺血后处理和环磷酸鸟苷升高剂的心脏保护作用涉及心肌细胞一氧化氮敏感的鸟苷酸环化酶。
Cardiovasc Res. 2018 May 1;114(6):822-829. doi: 10.1093/cvr/cvy039.
9
Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.一氧化氮非依赖性可溶性鸟苷酸环化酶刺激剂 BAY 41-2272 在大鼠气管平滑肌松弛活性的机制。
Eur J Pharmacol. 2010 Oct 25;645(1-3):158-64. doi: 10.1016/j.ejphar.2010.07.028. Epub 2010 Jul 27.
10
Cardioprotective PKG-independent NO signaling at reperfusion.再灌注时心脏保护型 PKG 非依赖性 NO 信号转导。
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H2028-36. doi: 10.1152/ajpheart.00527.2010. Epub 2010 Sep 17.

引用本文的文献

1
The Role of Vericiguat in Heart Failure Therapy: From Clinical Trials to Clinical Practice.维立西呱在心力衰竭治疗中的作用:从临床试验到临床实践
Rev Cardiovasc Med. 2025 Aug 29;26(8):39886. doi: 10.31083/RCM39886. eCollection 2025 Aug.
2
Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials.可溶性鸟苷酸环化酶刺激剂对心血管的影响:一项随机对照试验的荟萃分析。
Curr Atheroscler Rep. 2024 May;26(5):177-187. doi: 10.1007/s11883-024-01197-4. Epub 2024 Apr 2.
3
Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion.

本文引用的文献

1
Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.西那卡塞,一种新型可溶性鸟苷酸环化酶激活剂,可预防缺血/再灌注损伤:硫化氢的作用。
Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1347-54. doi: 10.1152/ajpheart.00544.2011. Epub 2012 Jan 20.
2
cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.cGMP-cAMP 相互作用在心肌细胞中:局部事件对心脏功能产生深远影响。
Biochem Soc Trans. 2012 Feb;40(1):11-4. doi: 10.1042/BST20110655.
3
Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
靶向缺血再灌注期间的可溶性鸟苷酸环化酶。
Cells. 2023 Jul 21;12(14):1903. doi: 10.3390/cells12141903.
4
Bibliometric study of soluble guanylate cyclase stimulators in cardiovascular research based on web of science from 1992 to 2021.基于科学网1992年至2021年数据的心血管研究中可溶性鸟苷酸环化酶刺激剂的文献计量学研究
Front Pharmacol. 2022 Aug 23;13:963255. doi: 10.3389/fphar.2022.963255. eCollection 2022.
5
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.cGMP 成为关注焦点:激活心脏保护性 PKG 途径的新兴策略。
Basic Res Cardiol. 2018 May 15;113(4):24. doi: 10.1007/s00395-018-0679-9.
6
Obestatin regulates cardiovascular function and promotes cardioprotection through the nitric oxide pathway.肥胖抑制素通过一氧化氮途径调节心血管功能并促进心脏保护。
J Cell Mol Med. 2017 Dec;21(12):3670-3678. doi: 10.1111/jcmm.13277. Epub 2017 Jul 26.
7
Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts.可溶性鸟苷酸环化酶激活剂BAY 60-2770激活蛋白激酶G对缺血再灌注损伤大鼠心脏的心脏保护作用
PLoS One. 2017 Jul 3;12(7):e0180207. doi: 10.1371/journal.pone.0180207. eCollection 2017.
8
BAY 41-2272 Treatment Improves Acetylcholine-Induced Aortic Relaxation in L-NAME Hypertensive Rats.BAY 41-2272治疗可改善L-NAME高血压大鼠中乙酰胆碱诱导的主动脉舒张功能。
Int J Angiol. 2016 Dec;25(4):235-240. doi: 10.1055/s-0036-1579625. Epub 2016 Apr 4.
9
Widening and Elaboration of Consecutive Research into Therapeutic Antioxidant Enzyme Derivatives.治疗性抗氧化酶衍生物连续研究的拓展与细化
Oxid Med Cell Longev. 2016;2016:3075695. doi: 10.1155/2016/3075695. Epub 2016 Apr 11.
10
Soluble guanylate cyclase activation during ischemic injury in mice protects against postischemic inflammation at the mitochondrial level.小鼠缺血性损伤期间可溶性鸟苷酸环化酶的激活可在线粒体水平预防缺血后炎症。
Am J Physiol Gastrointest Liver Physiol. 2016 May 1;310(9):G747-56. doi: 10.1152/ajpgi.00323.2015. Epub 2016 Feb 25.
荧光淬灭使无血红素可溶性鸟苷酸环化酶在活细胞中可检测到。
PLoS One. 2011;6(8):e23596. doi: 10.1371/journal.pone.0023596. Epub 2011 Aug 17.
4
Cardioprotective PKG-independent NO signaling at reperfusion.再灌注时心脏保护型 PKG 非依赖性 NO 信号转导。
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H2028-36. doi: 10.1152/ajpheart.00527.2010. Epub 2010 Sep 17.
5
Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.通过 cGMP 依赖性蛋白激酶的反馈控制有助于调节和区室化大鼠心肌细胞中的 cGMP。
Circ Res. 2010 Nov 12;107(10):1232-40. doi: 10.1161/CIRCRESAHA.110.226712. Epub 2010 Sep 16.
6
Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.一氧化氮非依赖性可溶性鸟苷酸环化酶刺激剂 BAY 41-2272 在大鼠气管平滑肌松弛活性的机制。
Eur J Pharmacol. 2010 Oct 25;645(1-3):158-64. doi: 10.1016/j.ejphar.2010.07.028. Epub 2010 Jul 27.
7
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.后处理和再灌注损伤保护:我们处于什么位置?来自欧洲心脏病学会心脏细胞生物学工作组的立场文件。
Cardiovasc Res. 2010 Aug 1;87(3):406-23. doi: 10.1093/cvr/cvq129. Epub 2010 May 6.
8
BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts.BAY 58-2667,一种不依赖一氧化氮的鸟苷酸环化酶激活剂,对兔和大鼠心脏进行药理后适应处理。
Eur Heart J. 2009 Jul;30(13):1607-13. doi: 10.1093/eurheartj/ehp143. Epub 2009 Apr 30.
9
Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.在暴露于氧化应激的细胞中,HMR-1766(阿他西呱)对可溶性鸟苷酸环化酶的激活作用。
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1763-71. doi: 10.1152/ajpheart.51.2008. Epub 2008 Aug 29.
10
Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.探究细胞内一氧化氮受体中配体结合血红素的存在情况。
Br J Pharmacol. 2008 Apr;153(7):1495-504. doi: 10.1038/sj.bjp.0707687. Epub 2008 Jan 21.